HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Biotechnology

Cancer Biotechnology

Cancer research is increasingly intertwined with biotechnology, leveraging cutting-edge tools and methodologies to unravel the complexities of this disease. From high-resolution imaging techniques facilitating early detection to customized therapies tailored to individual genetic profiles, biotechnology is reshaping how we approach cancer treatment. Biomarker identification, genomic sequencing, and precision medicine strategies are at the forefront, guiding clinicians towards more targeted and effective interventions. Moreover, innovative drug delivery systems, like nanoparticles and gene editing technologies, hold promise for reducing side effects and enhancing therapeutic outcomes. This fusion of cancer research and biotechnology heralds a new era in oncology, offering unprecedented opportunities to combat this formidable adversary and improve patient care worldwide.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp